ENTITY

Medexus Pharmaceuticals (MEDXF US)

17
Analysis
Health Care • Canada
Medexus Pharmaceuticals Inc. operates as a pharmaceutical company. The Company focuses on therapeutic areas such as rheumatology, auto-immune disease, specialty oncology, and pediatrics. Medexus Pharmaceuticals serves customers North America and Canada.
more
bullish•Lionsgate Studios
•20 Apr 2026 10:02

Weekly Update (LION, STRZ, MEDXF, UNTC, TRAX)

Small caps have spent four-plus years trapped below their November 2021 peak while large caps ran the show. That changed this week...

Logo
195 Views
Share
bullish•Hexagon
•06 Apr 2026 09:58

Weekly Update (LBTYA, MEDXF, APTV/CGNT)

In late May, Hexagon AB (Nasdaq Stockholm: HEXA B) will spin-off its software business, Octave Intelligence. Octave (represents ~25% of total...

Logo
167 Views
Share
bullish•Novartis
•16 Feb 2026 09:10

Weekly Update (ANGI, MEDXF, RNA)

Novartis (NVS) has agreed to acquire Avidity Biosciences (RNA) in the first half of 2026. As part of the transaction, Novartis will acquire...

Logo
368 Views
Share
bullish•Comcast Corp Class A
•29 Dec 2025 09:22

Weekly Update (VSNT, NLOP, MEDXF )

Comcast (CMCSA) plans to spin off its cable networks business, Versant (VSNT) in early 2026, with regular-way trading expected to begin on January...

Logo
236 Views
Share
bullish•Comcast Corp Class A
•24 Nov 2025 13:00

Weekly Update (MEDXF, MAGN, LEN/MRP, MODG)

Comcast (CMCSA) announced in late 2024 that it would spin off a bundle of its traditional U.S. cable networks and related digital properties into...

Logo
271 Views
Share
x